Breast cancer therapy: 10 products to dominate market by 2017 says new report

‘Breast Cancer Drug Discoveries: What the future holds’The report ‘Breast Cancer Drug Discoveries: What the future holds (%20http:/www.pharmaceutical-market-research.com/publications/drug_discovery/breast_cancer_drug_discoveries_future_holds_2008.html)’ states that key therpeutic brands achieved sales of US$12.7 billion in 2010, with growth due to higher sales for a number of treatments rather than the launch of new products. In 2010, nearly 50% of breast cancer sales were due to three branded targeted therapies. With a large unmet clinical need, further agents are necessary to increase